Navigation Links
Kendle Hires Satish Tripathi, PhD, RAC as Vice President, Global Regulatory and Quality
Date:2/1/2008

Board-Certified Regulatory Affairs Professional Brings More Than Two

Decades of Pharmaceutical, Regulatory Agency and Research Experience

CINCINNATI, Feb. 1 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced the hiring of Satish Tripathi, PhD, RAC as Vice President, Global Regulatory and Quality. Dr. Tripathi will provide additional leadership to the Regulatory Affairs Brand, overseeing the multi-functional global regulatory group consisting of approximately 450 personnel. He will focus on driving growth in the company's regulatory brand, which includes strategic clinical development planning, regulatory consulting and submissions, clinical trial regulatory affairs, nonclinical consulting, Chemistry, Manufacturing and Controls (CMC) development, medical writing and pharmacovigilance/safety services.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO )

"We are thrilled to have someone with Satish's background and experience as part of our regulatory leadership team," said Melanie Bruno, PhD, Vice President, Global Regulatory Affairs, Quality and Safety. "His ability to analyze the regulatory complexities of drug development and fashion a market positioning strategy to help ensure commercial success will provide a wonderful resource to Kendle's customers."

Dr. Tripathi served most recently as the Director of Worldwide Regulatory Strategy at Pfizer (formerly Pharmacia). Prior to that, he was a Director of Global Regulatory Affairs at the Biosciences Division of Baxter Healthcare Corporation in charge of all global regulatory submissions within the Recombinant Strategic Business Unit. While at the U.S. Food and Drug Administration, Dr. Tripathi served as a Pharmacology and Toxicology Reviewer with an emphasis on oncology and pulmonary products.

Dr. Tripathi earned his doctorate from the University of Glasgow in Scotland, his Master of Philosophy from Bhopal University in India and bachelor's and master's degrees from Jiwaji University at Gwalior, India. His post-doctoral fellowships include the Massachusetts Institute of Technology, Emory University Medical School and the Medical College of Wisconsin.

Dr. Tripathi will be based in Kendle's Chicago office.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is among the world's leading global clinical research organizations. We deliver innovative and robust clinical development solutions -- from first-in-human studies through market launch and surveillance -- to help the world's biopharmaceutical companies maximize product life cycles and grow market share.

Our global clinical development business is focused on five regions -- North America, Europe, Asia/Pacific, Latin America and Africa -- to meet customer needs. We have conducted clinical trials and provided regulatory and pharmacovigilance services in more than 80 countries. The company was named the "Top CRO to Work With" in the Thomson CenterWatch 2007 Survey of U.S. Investigative Sites and named "Best CRO" for the second consecutive year by leading global pharmaceutical publication Scrip.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 1200, Cincinnati, OH 45202 or from the Company's Web site at http://www.kendle.com.


'/>"/>
SOURCE Kendle International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Kendle to Present at the Wachovia 2008 Healthcare Conference
2. Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant
3. Kendle Named Best CRO for Second Consecutive Year by Leading Global Pharmaceutical Publication Scrip
4. Kendle Invites You to Attend Its Third Quarter 2007 Earnings Conference Call and Webcast
5. Kendle to Present at the Natixis Bleichroeder Hidden Gems Conference
6. Kendle to Present at the UBS Global Life Sciences Conference
7. Kendle to Present at Bear Stearns 20th Annual Healthcare Conference
8. Kendle to Present at Thomas Weisel Partners Healthcare Conference 2007
9. Kendle Marks 10th Anniversary as Public Company With NASDAQ Opening Bell Ceremony and Investor Day Event
10. Kendle to Ring Opening Bell at NASDAQ Stock Market on August 22
11. Medpace Hires Clinical Pharmacologist, Jim Wei, MD, PhD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... Properties (NYSE: CUZ ) announced today that Amgen, ... 10-year, approximately 125,000 square-foot lease at Corporate Center, a 1,224,000 ... submarket of Tampa, FL. ... for their new location in Tampa ," ... of Cousins Properties. "Amgen is a cutting-edge global company at ...
(Date:3/27/2017)... The new research portal will give visitors quick ... Valero Energy , offering extensive market research on their ... ... The latest trend gaining momentum in ... even though touted as a green alternative to fossil fuels, ...
(Date:3/27/2017)... , March 27, 2017 Neurotrope, ... novel therapies for neurodegenerative diseases, including Alzheimer,s disease, ... its application to list the Company,s common stock ... by The NASDAQ Stock Market, a unit of ... listing, Neurotrope will ring the Opening Bell at the ...
(Date:3/24/2017)... -- On Thursday, March 23, 2017, the ... 0.07%; the Dow Jones Industrial Average edged 0.02% lower, ... at 2,345.96, marginally dropping 0.11%. US markets saw a ... sectors finished in red, and 1 sector ended flat ... coverage on the following Biotechnology equities: BioDelivery Sciences International ...
Breaking Biology Technology:
(Date:3/24/2017)... , Mar 24, 2017 Research and Markets ... System Market Analysis & Trends - Industry Forecast to 2025" ... ... grow at a CAGR of around 15.1% over the next decade ... industry report analyzes the market estimates and forecasts for all the ...
(Date:3/22/2017)... Lithuania , March 21, 2017   ... and object recognition technologies, today announced the release ... kit (SDK), which provides improved facial recognition using ... cameras on a single computer. The new version ... to improve accuracy, and it utilizes a Graphing ...
(Date:3/20/2017)... HANOVER, Germany , March 20, 2017 At ... Hamburg -based biometrics manufacturer DERMALOG. The Chancellor came to the ... Japan is this year,s CeBIT partner country. At the largest ... important biometrics in use: fingerprint, face and iris recognition as well as ... ...
Breaking Biology News(10 mins):